20
Curia Spain Sau, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their notable products is BETAMETHASONE DIPROPIONATE, with a corresponding US DMF Number 17046.
Remarkably, this DMF maintains an Active status since its submission on December 23, 2003, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 05, 2015, and payment made on September 24, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II